Pfizer to pay $250m for Nexium
Tuesday, January 15, 2013 - 04:57
in Mathematics & Economics
AstraZeneca has sold rights to an over the counter version of its heartburn tablets
AstraZeneca has sold rights to an over the counter version of its heartburn tablets